Science Explorer Back to mapMap
Discussion
Institution · Ark Therapeutic (United States)

Most cited papers from Ark Therapeutic (United States)

Ark Therapeutic (United States)

What are the most cited papers from Ark Therapeutic (United States)?

The most cited paper from Ark Therapeutic (United States) is "Pharmaceutical Particle Engineering via Spray Drying" (Reinhard Vehring, 2007), with 1,690 citations. Next come "Macrophage-Based Approaches for Cancer Immunotherapy" (729) and "Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy" (405).

Showing 50 of 63 papers. Every paper with more than 7 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Pharmaceutical Particle Engineering via Spray Drying Reinhard Vehring · Pharmaceutical Research Open access 26 Nov 2007 1,690
2 Macrophage-Based Approaches for Cancer Immunotherapy Nicholas R. Anderson, Nicholas G. Minutolo, Saar I. Gill et al. · Cancer Research Open access 17 Nov 2020 729
3 Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy Albert M. Maguire, Stephen R. Russell, Jennifer A. Wellman et al. · Ophthalmology Open access 22 Jun 2019 405
4 Neuropilins: structure, function and role in disease Caroline Pellet‐Many, Paul Henry Frankel, Haiyan Jia et al. · Biochemical Journal 27 Mar 2008 391
5 Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells Rafat Abonour, David A. Williams, Lawrence H. Einhorn et al. · Nature Medicine Jun 2000 278
6 Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial Hugh Montgomery et al. · The Lancet Respiratory Medicine Open access278 authors 7 Jun 2022 230
7 Small Molecule Inhibitors of the Neuropilin-1 Vascular Endothelial Growth Factor A (VEGF-A) Interaction Ashley Jarvis, C.K. Allerston, Haiyan Jia et al. · Journal of Medicinal Chemistry Open access 12 Feb 2010 203
8 Challenges in monoclonal antibody-based therapies Haritha Dhammika Samaranayake, Thomas Wirth, Diana Schenkwein et al. · Annals of Medicine Open access 2009 177
9 The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene Daniel C. Chung et al. · American Journal of Ophthalmology Open access 27 Sep 2018 136
10 Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study David Neal Liebowitz, Keith A. Gottlieb, Nikita S. Kolhatkar et al. · The Lancet Infectious Diseases 21 Jan 2020 115
11 Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity Huimin Jia, Lili Cheng, Michelle L. Tickner et al. · British Journal of Cancer Open access 19 Jan 2010 98
12 Predicting crystal form stability under real-world conditions Dzmitry S. Firaha et al. · Nature Open access 8 Nov 2023 96
13 Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood Corinne J. Smith, Nikki L. Ross, Ali Kamal et al. · Frontiers in Immunology Open access 16 Sep 2022 83
14 Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo Minna Unelma Kaikkonen, Jani Kristian Räty, Kari J. Airenne et al. · Gene Therapy 3 Nov 2005 81
15 Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia Joseph Mendels, Ari Kiev, Louis F. Fabre · Depression and Anxiety Open access 1999 69
16 Cysteine-Rich and Basic Domain HIV-1 Tat Peptides Inhibit Angiogenesis and Induce Endothelial Cell Apoptosis Haiyan Jia, Marianne Löhr, Sylvie Jezequel et al. · Biochemical and Biophysical Research Communications May 2001 60
17 Functional comparison of PBMCs isolated by Cell Preparation Tubes (CPT) vs. Lymphoprep Tubes Han M. Chen, Christian M. Schürch, Kevin Noble et al. · BMC Immunology Open access 30 Mar 2020 59
18 Drug Delivery from an Innovative LAMA/LABA Co-suspension Delivery Technology Fixed-Dose Combination MDI: Evidence of Consistency, Robustness, and Reliability Amber Doty, Jon Schroeder, Kou Vang et al. · AAPS PharmSciTech Open access 10 Oct 2017 59
19 Magnetic resonance imaging of viral particle biodistribution in vivo Jani Kristian Räty, Timo Liimatainen, Thomas Wirth et al. · Gene Therapy 20 Jul 2006 56
20 Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation Amal Abu‐Ghosh, Stanton C. Goldman, Victoria Slone et al. · Bone Marrow Transplantation Sep 1999 56
21 Equivalence Considerations for Orally Inhaled Products for Local Action—ISAM/IPAC-RS European Workshop Report Carole D. Evans et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery 13 Mar 2012 56
22 Landscape of coordinated immune responses to H1N1 challenge in humans Zainab Rahil et al. · Journal of Clinical Investigation Open access 11 Oct 2020 52
23 KCNJ2 inhibition mitigates mechanical injury in a human brain organoid model of traumatic brain injury Jesse D. Lai, Joshua E. Berlind, Gabriella Fricklas et al. · Cell stem cell Open access Apr 2024 48
24 A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD Gregory Feldman, François Maltais, Sanjeev K. Khindri et al. · International Journal of COPD Open access Apr 2016 47
25 Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery Peter Dreger, Karin Viehmann, Nils v. Neuhoff et al. · Bone Marrow Transplantation Jul 1999 45
26 Peptides Encoded by Exon 6 of VEGF Inhibit Endothelial Cell Biological Responses and Angiogenesis Induced by VEGF Haiyan Jia, Sylvie Jezequel, Marianne Löhr et al. · Biochemical and Biophysical Research Communications Apr 2001 45
27 SL ‐401 and SL ‐501, targeted therapeutics directed at the interleukin‐3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia Olga Frolova, Juliana Benito, Christopher L. Brooks et al. · British Journal of Haematology Open access 19 Jun 2014 41
28 The role of neuropilins in cell signalling Ian C. Zachary, Paul Henry Frankel, Ian M. Evans et al. · Biochemical Society Transactions 19 Nov 2009 41
29 Human influenza virus challenge identifies cellular correlates of protection for oral vaccination David Robert McIlwain, Han M. Chen, Zainab Rahil et al. · Cell Host & Microbe Open access 15 Nov 2021 37
30 Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells Animesh Dev Pardanani, Terra L. Lasho, Dong Chen et al. · Leukemia 2 Feb 2015 36
31 Structure of anellovirus-like particles reveal a mechanism for immune evasion Shu-Hao Liou, Rajendra Boggavarapu, Noah R. Cohen et al. · Nature Communications Open access 22 Aug 2024 35
32 Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial Jaya Goswami et al. · The Lancet Infectious Diseases 110 authors 25 Nov 2024 34
33 Targeting and Purification of Metabolically Biotinylated Baculovirus Minna Unelma Kaikkonen, Jenni I. Viholainen, Ale T. O. Närvänen et al. · Human Gene Therapy 14 May 2008 33
34 Activity of tarloxotinib‐E in cells with EGFR exon‐20 insertion mutations and mechanisms of acquired resistance Masaya Nishino, Kenichi Suda, T. Koga et al. · Thoracic Cancer Open access 12 Mar 2021 29
35 Optimization of Drug Candidates That Inhibit the D‐Loop Activity of RAD51 Brian Budke, W. TUECKMANTEL, Kelsey Miles et al. · ChemMedChem Open access 8 Apr 2019 27
36 Production of HIV-1 Integrase Fusion Protein-Carrying Lentiviral Vectors for Gene Therapy and Protein Transduction Diana Schenkwein, Vesa Turkki, Hanna-Riikka Kärkkäinen et al. · Human Gene Therapy 29 Dec 2009 27
37 Future Prospects and Challenges of Antiangiogenic Cancer Gene Therapy Haritha Dhammika Samaranayake, Ann‐Marie Määttä, Jere T. Pikkarainen et al. · Human Gene Therapy 17 Feb 2010 25
38 GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers Gaia Bianco et al. · Communications Biology Open access 19 Apr 2022 24
39 A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease Colin Reisner, Leonardo Michele Fabbri, Edward Kerwin et al. · Respiratory Research Open access 6 Jan 2017 24
40 A Two One-Sided Parametric Tolerance Interval Test for Control of Delivered Dose Uniformity. Part 1—Characterization of FDA Proposed Test Steven J. Novick, David Christopher, Monisha Dey et al. · AAPS PharmSciTech Open access 23 Jun 2009 23
41 Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease Stephen I. Rennard, Charles M. Fogarty, Colin Reisner et al. · BMC Pulmonary Medicine Open access 16 Jul 2014 23
42 Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis Ankur Tiwari, Karl Christian Alcover, Elizabeth L. Carpenter et al. · Human Vaccines & Immunotherapeutics ReviewOpen access 27 Mar 2024 19
43 Interaction of the ARF tumor suppressor with cytosolic HSP70 contributes to its autophagy function Julia S. Pimkina, Maureen E. Murphy · Cancer Biology & Therapy Open access 15 Sep 2011 19
44 Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Naveen Pemmaraju, Éric Deconinck, Priyanka Mehta et al. · Clinical Lymphoma Myeloma & Leukemia Open access 20 Dec 2023 17
45 24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD Colin Reisner, Gregory M. Gottschlich, Faisal Fakih et al. · Respiratory Research Open access 18 Aug 2017 16
46 Hormonally Active Contraceptives Part I: Risks Acknowledged and Unacknowledged William V. Williams, JOEL L. BRIND, Laura Haynes et al. · The Linacre Quarterly Open access 27 Jan 2021 15
47 Trial by “Firsts”: Clinical Trial Design and Regulatory Considerations in the Development and Approval of the First AAV Gene Therapy Product in the United States Kathleen Z. Reape, Katherine A. High · Cold Spring Harbor Perspectives in Medicine Open access 12 Sep 2022 14
48 Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study T. Koga, Kenichi Suda, Masaya Nishino et al. · Translational Lung Cancer Research Open access 23 Jul 2021 14
49 ACTIVATION OF PRIMARY PORCINE ENDOTHELIAL CELLS INDUCES RELEASE OF PORCINE ENDOGENOUS RETROVIRUSES Deirdre Cunningham, Gabriella J. Dos Santos Cruz, Xosé M. Fernández et al. · Transplantation Apr 2004 14
50 Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients Naveen Pemmaraju, Branko Cuglievan, Joseph A. Lasky et al. · eJHaem Open access Feb 2024 13

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.